ReviewExpert opinion on investigational drugs2026

Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma.

Carlota Pagès-Geli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.